NATIONAL BANK OF CANADA /FI/ - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,078
-10.4%
3300.0%0.00%
Q2 2023$7,903
+27.4%
3300.0%0.00%
Q1 2023$6,205
+18.3%
3300.0%0.00%
Q4 2022$5,247
+4.9%
3300.0%0.00%
Q3 2022$5,000
+25.0%
330
+11.9%
0.00%
Q2 2022$4,000
-42.9%
2950.0%0.00%
Q1 2022$7,0002950.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders